2025 is coming to an end, and we would like to take this opportunity to thank our authors, editors, and reviewers for supporting us! Take a look at our group’s highlights from 2025 — achievements that wouldn’t have been possible without! Happy holidays! https://t.co/9jOQBX3v0C
At the Cochrane Collaboration, we are reviewing our use of X as a communications platform. In the meantime, we are pausing our engagement with the platform. Please see https://t.co/ICUC98l23R or follow us on LinkedIn (https://t.co/U03qUBZDlM) for the latest news and updates.
Main findings: for the surgical treatment of endometriomas, excision may be better than drainage and ablation for improving painful periods, pain during sex, the risk of endometriomas returning, and the risk of needing more surgery
#CochraneDaily 🎧 PODCAST 🎧 In one of the last @CochraneLibrary podcasts, Marian Showell from the University of Auckland in New Zealand describes the updated Cochrane Methodology Review of publication bias, containing more than 200 studies https://t.co/u3iHAo3CSj @AucklandUni
#CochraneDaily 🎧 PODCAST 🎧Cochrane Denmark's Jeppe Bennekou Schroll & Cecilie Jespersen discuss @CochraneLibrary review of selective serotonin reuptake inhibitors for women with premenstrual syndrome and premenstrual dysphoric disorder
https://t.co/6b2a5rDvnF @CochraneDK#PMS
New #podcast!
What are the benefits and risks of treating premenstrual syndrome and premenstrual dysphoric disorder with selective serotonin reuptake inhibitors?
https://t.co/DaGLRAVKc1
@jeppeschroll
The results of our trial on blastocyst versus cleavage stage embryo transfer in women with a good prognosis undergoing IVF are now available: https://t.co/IHJFmg4xWJ @bmj_latest#IVF
Here are our @CochraneCGF highlights for #2023. We thank all our editors, authors, reviewers, and consumers for their dedication and contribution!
Merry Xmas and a Happy New Year!
https://t.co/qwF94Qi8y6
Based on currently available #evidence there are no indications that #SARSCoV2 infection increases the risk of #miscarriage.
Special thanks to all co-authors, collaborators, and medical students that took part in this project!
We are happy to share our latest systematic review and meta-analysis on the risk and prevalence of pregnancy loss in women with #SARSCoV2 infection
@WelyMadelon
#covid#miscarriage
https://t.co/RWzQtnH0GZ
Just published! New #Cochrane review of Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle. Read it here: https://t.co/CXBeR6kv5h
🎉 Congratulations to the 2023 Anne Anderson Award winner, Madelon van Wely @WelyMadelon
🏆 This Prize is given to recognize and stimulate individuals contributing to the enhancement of women’s visibility and participation in Cochrane’s leadership.
https://t.co/XL3KEtLzmq
Just published! 2 studies added in this updated #Cochrane review of timed intercourse for couples trying to conceive. Read the review here: https://t.co/CO2gK25BjC. #conception